SK Hynix Reports Record Q1 Profit Surge Driven by AI Memory Chip Demand 
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs 
Tesla Earnings Beat Expectations as EV Growth Holds Amid Robotics and AI Shift 
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases 
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations 
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges 
Kakaku.com Stock Surges on EQT Takeover Interest Amid Rising Japan Deal Activity 
Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast 
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure 
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting 
PLS Reports Record Lithium Output as EV Demand Fuels Market Growth 
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy 
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO 
Meta Expands AI Training With Employee Activity Tracking Tools 
$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion 
European Car Sales Surge in March as EV and Hybrid Demand Accelerates 
LONDON, March 29, 2017 -- APCER Life Sciences, the truly global provider of safety, medical, regulatory and technology services, announced today that it will now offer Quality Assurance (QA) Auditing as a stand-alone service. The launch of QA Auditing and Consultancy services from APCER makes available resources knowledgeable in the complex ecosystem of international regulations, internal practices, and external relationships that companies in the pharmaceutical industry seek to ensure global compliance.
“Today’s announcement is really a formalization of a capability that many of our current clients have already taken advantage of,” said Michael Britt, Head of the EU business unit for APCER Life Sciences. “We have grown our global Quality and Compliance organization to the size where we feel confident to offer our specialized expertise to the industry as a stand-alone service apart from support of our operational clients in clinical safety, post-marketing pharmacovigilance, and medical affairs.”
APCER will offer a wide range of audits, such as Good Pharmacovigilance Practice, Good Clinical Practice, and Good Manufacturing Practice, as well as Information Technology & Computer Systems Validation and the increasingly important Vendor Audit. Consultancy in the areas of Quality Risk Management, Inspection Preparation & Training, Mock Inspections, Gap Analysis, Quality Management Systems, and Learning Management is also available.
“Our QA Auditing and Consultancy services draw on the experience of a global team of expert auditors and other QA professionals to help pharmaceutical companies meet their regulatory obligations,” said Luke Keitel, Global Head of Quality and Compliance at APCER Life Sciences. “The offering is in direct response to the escalating complexity and cost of compliance that has driven organisations to outsource more of their audits to specialist service providers."
The announcement of QA Auditing and Consultancy services coincides with the opening of the DIA EuroMeeting 2017, an annual forum that brings together industry, academia, regulators, and patient representatives for thought-provoking sessions and candid discussion of common challenges. Representatives of APCER Life Sciences, including Michael Britt and Luke Keitel, will be on hand today through Friday, March 31, to debut the offering at Stand E10 in the Scottish Exhibition and Conference Centre in Glasgow, Scotland.
About APCER Life Sciences
APCER Life Sciences is committed to improving health in partnership with its clients. It brings together safety, medical, regulatory, and technology resources to ensure that patients receive the safest, most effective therapies possible.
To learn how APCER Life Sciences works together for better health, please follow the company on Twitter, LinkedIn, and Facebook; visit www.apcerls.com; and contact APCER at one of their global offices.
Contact for APCER Life Sciences: Jill Notte 609-436-4714 [email protected]
